» Authors » L Binder

L Binder

Explore the profile of L Binder including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 110
Citations 807
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kogler A, Sadoghi B, Draschl A, Chromy D, Binder L, Schiefer-Niederkorn A, et al.
J Eur Acad Dermatol Venereol . 2024 Apr; 39(2):389-397. PMID: 38606611
Background: The incidence of sexually transmitted infections (STIs) is unbridled and on the rise. Extragenital STIs (anal and pharyngeal infections) are commonly asymptomatic, resulting in delayed diagnosis and treatment and...
2.
Kaba H, Hasenkamp J, Tas H, Schulz M, Streit F, Eiffert H, et al.
J Hosp Infect . 2023 Nov; 143:160-167. PMID: 37939885
Background: Bacterial infection ranks amongst the most common causes of morbidity and mortality in patients undergoing allogeneic haematopoietic stem cell transplantation (alloHSCT). Although ciprofloxacin (CIP) prophylaxis is recommended, information on...
3.
Soh A, Binder L, Clough M, Hernandez M, Lefevre G, Mostert K, et al.
Pract Lab Med . 2018 Dec; 12:e00110. PMID: 30519621
Aims: This study assessed the performance of a new fully automated immunoassay, ARCHITECT B.R.A.H.M.S procalcitonin (PCT), comparing the results with other commercial assays on routine clinical specimens. Methods: At nine...
4.
Bar-Ilan A, Livnat T, Hoffmann M, Binder L, Zakar M, Guy R, et al.
Haemophilia . 2018 Mar; 24(3):477-486. PMID: 29537116
Introduction: Recombinant FVIIa (rFVIIa) is an effective treatment for haemophilia through frequent administration. However, the short half-life of rFVIIa decreases its prophylactic ability to reduce bleeding. Carboxy-terminal peptide (CTP)-modified FVIIa...
5.
Luers C, Schmidt A, Wachter R, Fritzsche F, Sutcliffe A, Kleta S, et al.
Herz . 2010 Oct; 35(7):488-95. PMID: 20927502
Purpose: NT-proBNP is an important prognostic predictor in patients with heart failure. However, it is unknown whether a change of NT-proBNP plasma levels in the early phase of decompensation might...
6.
Stahrenberg R, Edelmann F, Mende M, Kockskamper A, Dungen H, Scherer M, et al.
Diabetologia . 2010 Apr; 53(7):1331-40. PMID: 20386878
Aims/hypothesis: Hyperglycaemia and insulin resistance have been linked to diastolic dysfunction experimentally. We investigated the association between glucose metabolism and diastolic function along the whole spectrum of glucose metabolism states....
7.
Vorwerk C, Tuchen S, Streit F, Binder L, Hofmuller W, Behrens-Baumann W
Ophthalmic Res . 2009 Jan; 41(2):102-5. PMID: 19122472
Background: The echinocandin caspofungin (CAS) is a novel antifungal drug with fungicidal in vitro activity against all Candida spp., which are the most frequent cause of fungal keratitis. Penetration of...
8.
Vorwerk C, Streit F, Binder L, Tuchen S, Knop C, Behrens-Baumann W
Graefes Arch Clin Exp Ophthalmol . 2008 May; 246(8):1179-83. PMID: 18491124
Objectives: Voriconazol is a triazole antifungal drug with in vitro fungicidal activity against all Candida spp., Fusarium spp. and Aspergillus spp. which are frequent causes of fungal keratitis depending on...
9.
Michalsen A, Lehmann N, Pithan C, Knoblauch N, Moebus S, Kannenberg F, et al.
Eur J Clin Nutr . 2005 Nov; 60(4):478-85. PMID: 16306923
Objective: Mediterranean diet is associated with decreased levels of inflammatory markers and metabolic risk factors in epidemiologic studies and recent trials on patients with metabolic syndrome. Given the recent improvements...
10.
Mufson E, Counts S, Perez S, Binder L
Neuropeptides . 2005 May; 39(3):233-7. PMID: 15893372
Galanin (GAL) is a biologically active 29 amino acid (30 in humans) which participates in the modulation of several ascending neurotransmitter systems including cholinergic basal forebrain (CBF) neurons, which undergo...